[go: up one dir, main page]

WO1992001498A3 - Procede et dispositif d'analyse par precipitation en phase solide - Google Patents

Procede et dispositif d'analyse par precipitation en phase solide Download PDF

Info

Publication number
WO1992001498A3
WO1992001498A3 PCT/US1991/005004 US9105004W WO9201498A3 WO 1992001498 A3 WO1992001498 A3 WO 1992001498A3 US 9105004 W US9105004 W US 9105004W WO 9201498 A3 WO9201498 A3 WO 9201498A3
Authority
WO
WIPO (PCT)
Prior art keywords
fluid sample
hdl
matrix
vldl
ldl
Prior art date
Application number
PCT/US1991/005004
Other languages
English (en)
Other versions
WO1992001498A2 (fr
Inventor
Ronald M Jones
Original Assignee
Cholestech Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/554,147 external-priority patent/US5213965A/en
Application filed by Cholestech Corp filed Critical Cholestech Corp
Priority to JP3513080A priority Critical patent/JP2981774B2/ja
Priority to EP91913726A priority patent/EP0539495B1/fr
Priority to AT91913726T priority patent/ATE198796T1/de
Priority to KR1019930700111A priority patent/KR930701750A/ko
Priority to DE9117297U priority patent/DE9117297U1/de
Priority to AU82986/91A priority patent/AU656733B2/en
Priority to CA002087255A priority patent/CA2087255C/fr
Priority to DE69132513T priority patent/DE69132513T2/de
Publication of WO1992001498A2 publication Critical patent/WO1992001498A2/fr
Publication of WO1992001498A3 publication Critical patent/WO1992001498A3/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D39/00—Filtering material for liquid or gaseous fluids
    • B01D39/14—Other self-supporting filtering material ; Other filtering material
    • B01D39/20—Other self-supporting filtering material ; Other filtering material of inorganic material, e.g. asbestos paper, metallic filtering material of non-woven wires
    • B01D39/2003—Glass or glassy material
    • B01D39/2017—Glass or glassy material the material being filamentary or fibrous
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/60—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving cholesterol
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G01N33/525—Multi-layer analytical elements
    • G01N33/526—Multi-layer analytical elements the element being adapted for a specific analyte
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2239/00—Aspects relating to filtering material for liquid or gaseous fluids
    • B01D2239/04—Additives and treatments of the filtering material
    • B01D2239/0414—Surface modifiers, e.g. comprising ion exchange groups
    • B01D2239/0421—Rendering the filter material hydrophilic
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2239/00—Aspects relating to filtering material for liquid or gaseous fluids
    • B01D2239/04—Additives and treatments of the filtering material
    • B01D2239/0471—Surface coating material
    • B01D2239/0492—Surface coating material on fibres
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2326/00—Chromogens for determinations of oxidoreductase enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2326/00—Chromogens for determinations of oxidoreductase enzymes
    • C12Q2326/90—Developer
    • C12Q2326/96—4-Amino-antipyrine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/044—Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/104165—Lipid, cholesterol, or triglyceride standard or control

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Geology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Dispositif d'analyse (14) permettant de mesurer la concentration d'un analyte soluble, tel que le cholestérol associé à HDL, dans un échantillon fluide contenant des composés d'interférence tels que le cholestérol associé à LDL ou le cholestérol associé à VLDL, qui peuvent être précipités sélectivement. Le dispositif comprend une matrice de criblage (26) pouvant séparer le matériau soluble et précipité passant au travers de la matrice, et un réservoir (34) qui contient un agent de précipitation lequel est efficace, dans une plage de concentration donnée, pour précipiter sélectivement les composés d'interférence. Le réservoir est conçu pour retarder la libération de l'agent, lors du contact avec l'échantillon fluide, pour maintenir la concentration de l'agent de précipitation en contact avec l'échantillon fluide dans la plage de concentration donnée. Le dispositif comporte en outre un tampon d'analyse (64, 66, 68, 70) par lequel l'analyte soluble présent dans l'échantillon fluide peut être analysé. Un procédé de séparation de lipoprotéines très denses (HDL) de lipoprotéines de faible et de très faible densités (LDL et VLDL) utilise une matrice en fibres de verre revêtues qui inhibe la liaison de HDL comme un échantillon fluide de sang contenant HDL et LDL et VLDL précipités passent au travers de la matrice.
PCT/US1991/005004 1990-07-16 1991-07-15 Procede et dispositif d'analyse par precipitation en phase solide WO1992001498A2 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
JP3513080A JP2981774B2 (ja) 1990-07-16 1991-07-15 固相沈澱アッセイ装置および方法
EP91913726A EP0539495B1 (fr) 1990-07-16 1991-07-15 Procede et dispositif d'analyse de hdl-cholesterol par precipitation en phase solide
AT91913726T ATE198796T1 (de) 1990-07-16 1991-07-15 Vorrichtung und verfahren zur festphase- präzipitationsbestimmung von hdl-cholesterin
KR1019930700111A KR930701750A (ko) 1990-07-16 1991-07-15 고상 침전검정장치와 그 방법
DE9117297U DE9117297U1 (de) 1990-07-16 1991-07-15 Vorrichtung zur Festphasen-Präzipdation
AU82986/91A AU656733B2 (en) 1990-07-16 1991-07-15 Solid-phase precipitation assay device and method
CA002087255A CA2087255C (fr) 1990-07-16 1991-07-15 Appareil et methode d'essai de precipitation en phase solide
DE69132513T DE69132513T2 (de) 1990-07-16 1991-07-15 Vorrichtung und verfahren zur festphase-präzipitationsbestimmung von hdl-cholesterin

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US07/554,147 US5213965A (en) 1990-07-16 1990-07-16 Solid-phase precipitation assay device
US554,147 1990-07-16
US07/729,447 US5213964A (en) 1990-07-16 1991-07-12 High-density lipoprotein solid-base precipitation assay method
US729,447 1991-07-12

Publications (2)

Publication Number Publication Date
WO1992001498A2 WO1992001498A2 (fr) 1992-02-06
WO1992001498A3 true WO1992001498A3 (fr) 1992-03-05

Family

ID=27070513

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1991/005004 WO1992001498A2 (fr) 1990-07-16 1991-07-15 Procede et dispositif d'analyse par precipitation en phase solide

Country Status (9)

Country Link
US (3) US5213964A (fr)
EP (2) EP1028319A3 (fr)
JP (1) JP2981774B2 (fr)
AT (1) ATE198796T1 (fr)
AU (1) AU656733B2 (fr)
CA (1) CA2087255C (fr)
DE (2) DE9117297U1 (fr)
ES (1) ES2155057T3 (fr)
WO (1) WO1992001498A2 (fr)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39915E1 (en) 1989-09-01 2007-11-06 Roche Diagnostics Gmbh Method for the determination of HDL cholesterol by means of a rapid diagnostic agent with an integrated fractionating step
DE3929032C2 (de) * 1989-09-01 1998-09-03 Boehringer Mannheim Gmbh Verfahren zur Bestimmung von HDL-Cholesterin mittels eines Schnelldiagnostikums mit integriertem Fraktionierschritt
US5213964A (en) * 1990-07-16 1993-05-25 Cholestech Corporation High-density lipoprotein solid-base precipitation assay method
US5286626A (en) * 1991-12-13 1994-02-15 Actimed Laboratories, Inc. Process and apparatus for direct determination of low density lipoprotein
JP2653755B2 (ja) * 1994-03-08 1997-09-17 協和メデックス株式会社 高密度リポ蛋白中のコレステロールの定量法
JP2600065B2 (ja) * 1994-03-08 1997-04-16 協和メデックス株式会社 高密度リポ蛋白中のコレステロールの定量法
CA2190282C (fr) * 1995-03-16 2004-09-28 Kazuhito Miyauchi Procede pour l'evaluation quantitative du cholesterol dans une lipoproteine faible densite
US7635597B2 (en) 1995-08-09 2009-12-22 Bayer Healthcare Llc Dry reagent particle assay and device having multiple test zones and method therefor
US5981294A (en) * 1995-11-29 1999-11-09 Metrika, Inc. Device for blood separation in a diagnostic device
US5968839A (en) * 1996-05-13 1999-10-19 Metrika, Inc. Method and device producing a predetermined distribution of detectable change in assays
US5945345A (en) * 1996-08-27 1999-08-31 Metrika, Inc. Device for preventing assay interference using silver or lead to remove the interferant
US20020182749A1 (en) * 1999-05-11 2002-12-05 Aclara Biosciences, Inc. Sample evaporative control
DE19962577A1 (de) * 1999-12-23 2001-07-12 Tittgen Biotechnologie Dr Chromatographiematerial und Verfahren unter Verwendung desselben
WO2002044695A1 (fr) * 2000-11-16 2002-06-06 Burstein Technologies, Inc. Methodes et appareils destines a la detection et au denombrement de lymphocytes utilisant des biodisques optiques
WO2003021222A2 (fr) * 2001-08-31 2003-03-13 Burstein Technologies, Inc. Ensembles a couche de capture destines a des analyses cellulaires, comportant des disques d'analyse optiques, et procedes correspondants
CN1659439A (zh) * 2001-09-07 2005-08-24 伯斯坦技术公司 利用光学生物盘系统基于细胞核形态学的白血细胞类型的识别和定量
EP1448992A4 (fr) * 2001-11-20 2005-11-02 Burstein Technologies Inc Biodisques optiques et circuits fluidiques utilises pour l'analyse de cellules et methodes correspondantes
EP1495335A2 (fr) 2001-12-21 2005-01-12 Polymer Technology Systems, Inc. Bandelette d'essai et procede pour determiner la concentration en cholesterol hdl a partir de sang entier ou de plasma
WO2003058239A2 (fr) 2001-12-28 2003-07-17 Polymer Technology Systems, Inc. Bande d'essai permettant de determiner une concentration de triglycerides
DE10204606C1 (de) * 2002-01-18 2003-10-16 Cholestech Corp Vorrichtung und Verfahren für Lipoproteine hoher Dichte
ATE309544T1 (de) * 2002-04-09 2005-11-15 Cholestech Corp Verfahren und vorrichtung zur quantifizierung von lipoprotein-cholesterol hoher dichte
EP1576351A4 (fr) * 2002-11-26 2010-06-23 Univ Utah Res Found Materiaux microporeux, procedes, et articles permettant de localiser et de quantifier des analytes
US7597936B2 (en) * 2002-11-26 2009-10-06 University Of Utah Research Foundation Method of producing a pigmented composite microporous material
TWI333545B (en) * 2003-04-02 2010-11-21 Cholestech Corp Adhered membranes retaining porosity and biological activity
US20050074828A1 (en) * 2003-07-16 2005-04-07 Dimagno Theodore John Uae of lipase for high-density lipoprotein cholesterol detection
ES2303882T3 (es) * 2003-11-04 2008-09-01 Cholestech Corporation Membranas y laminados que contienen reactivos y sus procedimientos de preparacion.
US7150995B2 (en) 2004-01-16 2006-12-19 Metrika, Inc. Methods and systems for point of care bodily fluid analysis
US7772007B2 (en) 2004-04-02 2010-08-10 Cholestech Corporation Assay device for direct measurement of LDL cholesterol
US7749775B2 (en) * 2006-10-03 2010-07-06 Jonathan Scott Maher Immunoassay test device and method of use
US7492312B2 (en) * 2006-11-14 2009-02-17 Fam Adly T Multiplicative mismatched filters for optimum range sidelobe suppression in barker code reception
US7824879B2 (en) * 2007-01-09 2010-11-02 Cholestech Corporation Device and method for measuring LDL-associated cholesterol
WO2009037784A1 (fr) * 2007-09-21 2009-03-26 Tya K. K. Instrument analytique pour composant de fluide corporel
US20110130473A1 (en) 2007-11-13 2011-06-02 Bio-Technology General (Israel) Ltd. Dilute filtration sterilization process for viscoelastic biopolymers
JP5313537B2 (ja) * 2008-04-10 2013-10-09 富士フイルム株式会社 高密度リポ蛋白コレステロール測定用乾式分析素子
WO2009152373A1 (fr) * 2008-06-13 2009-12-17 Polymer Technology Systems, Inc. Bande hybride
US9395373B2 (en) 2008-06-13 2016-07-19 Polymer Technology Systems, Inc. Hybrid strip
EP2387714B1 (fr) 2009-01-23 2018-03-14 Polymer Technology Systems, Inc. Bandelette réactive multicouche de diagnostic en phase sèche avec biocapteurs intégrés
US9562256B2 (en) * 2010-10-23 2017-02-07 Pop Test LLC Devices and formulations for detecting, screening and monitoring levels of certain constituents in bodily fluids and method
US20200400694A1 (en) * 2018-03-13 2020-12-24 Denka Company Limited Method for assisting determination of risk of cardiovascular disease or the like

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3797494A (en) * 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
US4215993A (en) * 1978-12-04 1980-08-05 Data Medical Associates, Inc. Precipitating reagent and method for isolation and determination of high density lipoproteins in human serum
EP0146654A2 (fr) * 1980-06-20 1985-07-03 Unilever Plc Procédé et dispositif pour la réalisation d'essais à liaison spécifique
WO1989005458A1 (fr) * 1987-12-03 1989-06-15 Oxford Virology Limited Procede servant a estimer les concentrations de cholesterol dans le sang
EP0353570A2 (fr) * 1988-07-30 1990-02-07 Roche Diagnostics GmbH Matrice de support imprégnée de réactifs pouvant être libérés
WO1990010869A1 (fr) * 1989-03-08 1990-09-20 Cholestech Corporation Dispositif et appareil de controle d'analytes
EP0415298A2 (fr) * 1989-09-01 1991-03-06 Roche Diagnostics GmbH Procédé pour la détermination d'HDL-cholestérine utilisant un élément analytique avec fractionnement intégré

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1095819A (fr) * 1977-01-14 1981-02-17 Eastman Kodak Company Element pour l'analyse des liquides
CH625399A5 (fr) * 1978-01-20 1981-09-30 Nestle Sa
US4188188A (en) * 1978-09-27 1980-02-12 Bio-Rad Laboratories, Inc. High density lipoprotein cholesterol assay
JPH0142041Y2 (fr) * 1978-12-11 1989-12-11
DE3029579C2 (de) * 1980-08-05 1985-12-12 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren und Mittel zur Abtrennung von Plasma oder Serum aus Vollblut
DE3208253A1 (de) * 1982-03-08 1983-09-15 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur spezifischen bestimmung des cholesterins der ldl-fraktion im serum
DE3215310A1 (de) * 1982-04-23 1983-10-27 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur bestimmung der low density lipoproteine (ldl) und reagenz zu seiner durchfuehrung
US4615946A (en) * 1985-03-29 1986-10-07 Ppg Industries, Inc. Chemically treated glass fibers for reinforcing polymeric matrices
JPS6211167A (ja) * 1985-07-09 1987-01-20 Fuji Photo Film Co Ltd コレステロ−ル分析用多層分析要素
US4711820A (en) * 1986-06-17 1987-12-08 Petrarch Systems Inc. Method of siliconization of surfaces with lower alkyl silanes
US4753776A (en) * 1986-10-29 1988-06-28 Biotrack, Inc. Blood separation device comprising a filter and a capillary flow pathway exiting the filter
US4987085A (en) * 1987-06-22 1991-01-22 Chemtrak Inc. Blood filtering metering device
US5082626A (en) * 1988-08-08 1992-01-21 Boehringer Mannheim Gmbh Wedge shaped test strip system useful in analyzing test samples, such as whole blood
JPH02210265A (ja) * 1989-02-10 1990-08-21 Konica Corp 分析素子
CA2019865A1 (fr) * 1989-07-12 1991-01-12 Yatin B. Thakore Procede et dispositif pour la separation des elements composant un fluide, en vue d'isoler certains elements utiles
US5213964A (en) * 1990-07-16 1993-05-25 Cholestech Corporation High-density lipoprotein solid-base precipitation assay method
US5213965A (en) * 1990-07-16 1993-05-25 Cholestech Corporation Solid-phase precipitation assay device

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3797494A (en) * 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
US4215993A (en) * 1978-12-04 1980-08-05 Data Medical Associates, Inc. Precipitating reagent and method for isolation and determination of high density lipoproteins in human serum
EP0146654A2 (fr) * 1980-06-20 1985-07-03 Unilever Plc Procédé et dispositif pour la réalisation d'essais à liaison spécifique
WO1989005458A1 (fr) * 1987-12-03 1989-06-15 Oxford Virology Limited Procede servant a estimer les concentrations de cholesterol dans le sang
EP0353570A2 (fr) * 1988-07-30 1990-02-07 Roche Diagnostics GmbH Matrice de support imprégnée de réactifs pouvant être libérés
WO1990010869A1 (fr) * 1989-03-08 1990-09-20 Cholestech Corporation Dispositif et appareil de controle d'analytes
EP0415298A2 (fr) * 1989-09-01 1991-03-06 Roche Diagnostics GmbH Procédé pour la détermination d'HDL-cholestérine utilisant un élément analytique avec fractionnement intégré

Also Published As

Publication number Publication date
DE69132513T2 (de) 2001-08-23
US5316916A (en) 1994-05-31
EP1028319A3 (fr) 2004-01-21
ATE198796T1 (de) 2001-02-15
US5451370A (en) 1995-09-19
ES2155057T3 (es) 2001-05-01
EP0539495A1 (fr) 1993-05-05
CA2087255A1 (fr) 1992-01-17
DE69132513D1 (de) 2001-02-22
CA2087255C (fr) 1999-08-31
JPH06502911A (ja) 1994-03-31
EP0539495B1 (fr) 2001-01-17
AU8298691A (en) 1992-02-18
DE9117297U1 (de) 2000-08-03
EP1028319A2 (fr) 2000-08-16
AU656733B2 (en) 1995-02-16
WO1992001498A2 (fr) 1992-02-06
US5213964A (en) 1993-05-25
JP2981774B2 (ja) 1999-11-22

Similar Documents

Publication Publication Date Title
WO1992001498A3 (fr) Procede et dispositif d'analyse par precipitation en phase solide
CA2023926C (fr) Methode de dosage du hdl cholesterol au moyen d'un agent de diagnostic rapide avec une etape de fractionnement integree
JP2868900B2 (ja) ワンステップ側方流非吸収性アッセイ
EP0556202B1 (fr) Analyse de detection amelioree de ligands
US4219335A (en) Immunochemical testing using tagged reagents
EP0306772A1 (fr) Dispositif pour essai de fixation chromatographique à écoulement latéral
EP0290921A3 (en) Test-piece for the analysis of a liquid sample and method for its preparation
FI903515A0 (fi) Testimenetelmä ja reagenssikitti sitä varten
AU2718895A (en) Test device and method for colored particle immunoassay
AU4888796A (en) Method and device for magnetically determining an analyte, particularly a bacterium
CA2048530A1 (fr) Membranes et membranes surajoutees pour exclure les erythrocytes lors de dosages de composants d'etat solide
US5753497A (en) Diagnostic assay providing blood separation
ATE48157T1 (de) Ein zwitterion als bindungsmittel enthaltende zusammensetzung und testvorrichtung zum nachweis von leukozyten.
US4939096A (en) Method and apparatus for assaying whole blood
GB2300914A (en) Analyte detection device for liquid samples
CA1122503A (fr) Epreuve immunochimique a l'aide de reactifs marques
JPS57103055A (en) Analysis of homogeneous peculiar bond and apparatus used therefor
GB1575998A (en) Extraction-free cortisol assay
US6228658B1 (en) Method of using a test strip for the immunochemical detection of substances
US4680273A (en) Assay for vitamin B12 deficiency
AU2353188A (en) A diagnostic agent and a method for the determination of apolipoprotein b
Hutchinson et al. Nickel hypersensitivity: Nickel binding to amino acids and lymphocytes
WO1994012879A1 (fr) Systeme a reactif sec de detection d'analyte a trois constituants
EP0617790B1 (fr) Systeme d'analyse de diagnostic
EP0007744A1 (fr) Procédé pour le dosage de la globuline fixatrice d'hormones thyroidiennes

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA FI JP KR NO

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU NL SE

AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA FI JP KR NO

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU NL SE

WWE Wipo information: entry into national phase

Ref document number: 2087255

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1991913726

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1991913726

Country of ref document: EP

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: PAT.BUL.04/92 UNDER INID (30) PRIORITY DATA REPLACE "544147" BY "07/554147"

WWG Wipo information: grant in national office

Ref document number: 1991913726

Country of ref document: EP